EUVIMEDEUVIMED entdecken
Crossref

PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program

Mirko V. Sikirica, Nazia Rashid, Ratna Revankar, James M. Youakim

Value in Health · 2025-07 · 28 (6) · S61

DOI: 10.1016/j.jval.2025.04.291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2025-07. Verfasst von Mirko V. Sikirica und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sikirica, M. V., Rashid, N., Revankar, R., & Youakim, J. M. (2025). PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program. Value in Health, 28(6), S61. https://doi.org/10.1016/j.jval.2025.04.291

Vancouver

Sikirica MV, Rashid N, Revankar R, Youakim JM. PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program. Value in Health. 2025;28(6):S61. doi:10.1016/j.jval.2025.04.291

BibTeX
@article{Sikirica2025,
  author = {Sikirica, Mirko V. and Rashid, Nazia and Revankar, Ratna and Youakim, James M.},
  title = {PT15 Assessing Minimal Clinically Important Differenceestimates for the Rett Syndrome Behavior Questionnaire (RSBQ) using Data from the Trofinetide Clinical Program},
  journal = {Value in Health},
  year = {2025},
  volume = {28},
  number = {6},
  pages = {S61},
  doi = {10.1016/j.jval.2025.04.291}
}
Kostenlos starten →